Cited by 354Prion Diseases and Protein MisfoldingAmyloidosis: Diagnosis, Treatment, OutcomesSleep and Wakefulness Research

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Familial and sporadic fatal insomnia

Abstract

Familial fatal insomnia (FFI)--a hereditary prion disease caused by a mutation at codon 178 of the prion-protein (PrP) gene (PRNP) that leads to a D178N substitution in the protein--and its sporadic form, sporadic fatal insomnia (SFI), have similar disease phenotypes. Both disorders have clinical features of disrupted sleep (loss of sleep spindles and slow-wave sleep and enacted dreams during rapid-eye-movement sleep), autonomic hyperactivation, and motor abnormalities (myoclonus, ataxia, dysarthria, dysphagia, and pyramidal signs). PET shows pronounced thalamic and limbic hypometabolism that becomes more widespread in later stages. Neuropathological assessment reveals severe neuronal loss and astrogliosis of the anterior medial thalamus and inferior olives, with later cerebral cortical and cerebellar involvement. Accumulation of an isoform of protease-resistant PrP fragment in FFI distinct from that found in a familial form of Creutzfeldt-Jakob disease with the same D178N mutation, shows the effect of the polymorphism at codon 129 of PRNP on phenotypic expression and the possibility of distinct prion "strains" with diverse pathological potential. Intriguing clinicopathological correlations in FFI and SFI suggest a role for the thalamolimbic system in the regulation of sleep and other circadian functions.

Overview

Integrity signals

Registry

Crossref · 10.1016/s1474-4422(03)00323-5

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Fatal familial or sporadic insomnia leads to dementia and death within months or years.

    “fatal familial or sporadic insomnia is a progressively worsening state of sleeplessness that leads to dementia and death within months or years (7).”

    From Sleep Drives Metabolite Clearance from the Adult Brain (2013) · cites this paper as [7]

Citations

Cites

Flagged first, then by citations

Research works printed but not linked: 119

  1. Lugaresi, 1986, Fatal familial insomnia and dysautonomia with selective degeneration of thalamic nuclei, N Engl J Med, 315, 997, 10.1056/NEJM198610163151605 · DOI
  2. Sforza, 1995, Sleep-wake cycle abnormalities in fatal familial insomnia: evidence of the role of the thalamus in sleep regulation, Electroencephalogr Clin Neurophysiol, 94, 398, 10.1016/0013-4694(94)00318-F · DOI
  3. Cortelli, 1991, Cardiovascular dysautonomia in fatal familial insomnia, Clin Auton Res, 1, 15, 10.1007/BF01826053 · DOI
  4. Gallassi, 1992, “Fatal familial insomnia”: neuropsychological study of a disease with thalamic degeneration, Cortex, 28, 175, 10.1016/S0010-9452(13)80046-9 · DOI
  5. Perani, 1993, [18F]FDG PET in fatal familial insomnia: the functional effects of thalamic lesions, Neurology, 43, 2565, 10.1212/WNL.43.12.2565 · DOI
  6. Manetto, 1992, Fatal familial insomnia: clinical and pathologic study of five new cases, Neurology, 42, 312, 10.1212/WNL.42.2.312 · DOI
  7. Padovani, 1998, Fatal familial insomnia in a new Italian kindred, Neurology, 51, 1491, 10.1212/WNL.51.5.1491 · DOI
  8. Medori, 1992, Fatal familial insomnia, a prion disease with a mutation at codon 178 of the prion protein gene, N Engl J Med, 326, 444, 10.1056/NEJM199202133260704 · DOI
  9. Medori, 1992, Fatal familial insomnia: a second kindred with mutation of prion protein gene at codon 178, Neurology, 42, 669, 10.1212/WNL.42.3.669 · DOI
  10. Monari, 1994, Fatal familial insomnia and familial Creutzfeldt-Jacob disease: different prion proteins determined by a DNA polymorphism, Proc Natl Acad Sci USA, 91, 2839, 10.1073/pnas.91.7.2839 · DOI
  11. Parchi, 1995, Regional distribution of protease-resistant prion protein in fatal familial insomnia, Ann Neurol, 38, 21, 10.1002/ana.410380107 · DOI
  12. Chen, 1997, Allelic origin of the abnormal prion protein isoform in familial prion diseases, Nat Med, 3, 1009, 10.1038/nm0997-1009 · DOI
  13. Goldfarb, 1992, Fatal familial insomnia and familial Creutzfeldt-Jakob disease: disease phenotype determined by a DNA polymorphism, Science, 258, 806, 10.1126/science.1439789 · DOI
  14. Montagna, 1998, Clinical features of fatal familial insomnia: phenotypic variability in relation to a polymorphism at codon 129 of the prion protein gene, Brain Pathol, 8, 515, 10.1111/j.1750-3639.1998.tb00172.x · DOI
  15. Parchi, 1999, A subtype of sporadic prion disease mimicking fatal familial insomnia, Neurology, 52, 1757, 10.1212/WNL.52.9.1757 · DOI
  16. Mastrianni, 1999, Prion protein conformation in a patient with sporadic fatal insomnia, N Engl J Med, 340, 1630, 10.1056/NEJM199905273402104 · DOI
  17. Tateishi, 1995, First experimental transmission of fatal familial insomnia, Nature, 376, 434, 10.1038/376434a0 · DOI
  18. Collinge, 1995, Transmission of fatal familial insomnia to laboratory animals, Lancet, 346, 569, 10.1016/S0140-6736(95)91405-6 · DOI
  19. Telling, 1996, Evidence for the conformation of the pathologic isoform of the prion protein enciphering and propagating prion diversity, Science, 274, 2079, 10.1126/science.274.5295.2079 · DOI
  20. Tabernero, 2000, Fatal familial insomnia: clinical, neuropathological, and genetic description of a Spanish family, J Neurol Neurosurg Psychiatry, 68, 774, 10.1136/jnnp.68.6.774 · DOI
  21. Colombier, 1997, Fatal familial insomnia: phenotypic changes determined by polymorphism of the codon 129, Rev Neurol (Paris), 153, 239
  22. Goldfarb, 1991, New mutation in scrapie amyloid precursor gene (at codon 178) in Finnish Creutzfeldt-Jakob kindred, Lancet, 337, 425, 10.1016/0140-6736(91)91198-4 · DOI
  23. Almer, 1999, Fatal familial insomnia: a new Austrian family, Brain, 122, 5, 10.1093/brain/122.1.5 · DOI
  24. Harder, 1999, Novel twelve-generation kindred of fatal familial insomnia from Germany representing the entire spectrum of disease expression, Am J Med Genet, 87, 311, 10.1002/(SICI)1096-8628(19991203)87:4<311::AID-AJMG6>3.0.CO;2-5 · DOI
  25. Silburn, 1996, Fatal familial insomnia: a seventh family, Neurology, 47, 1326, 10.1212/WNL.47.5.1326 · DOI
  26. Reder, 1995, Clinical and genetic studies of fatal familial insomnia, Neurology, 45, 1068, 10.1212/WNL.45.6.1068 · DOI
  27. Nagayama, 1996, Fatal familial insomnia with a mutation at codon 178 of the prion protein gene: first report from Japan, Neurology, 47, 1313, 10.1212/WNL.47.5.1313 · DOI
  28. Petersen, 1992, Analysis of the prion protein gene in thalamic dementia, Neurology, 42, 1859, 10.1212/WNL.42.10.1859 · DOI
  29. Kawasaki, 1997, Thalamic form of Creutzfeldt-Jakob disease or fatal insomnia? Report of a sporadic case with normal prion protein genotype, Acta Neuropathol(Berl), 93, 317, 10.1007/s004010050621 · DOI
  30. Will, 1984, A retrospective study of Creutzfeldt-Jakob disease in England and Wales 1970–79: I; clinical features, J Neurol Neurosurg Psychiatry, 47, 134, 10.1136/jnnp.47.2.134 · DOI
  31. Gajdusek, 1966, Experimental transmission of a kuru-like syndrome to chimpanzees, Nature, 209, 794, 10.1038/209794a0 · DOI
  32. Hsiao, 1989, Linkage of a prion protein missense variant to Gerstmann-Straussler syndrome, Nature, 338, 342, 10.1038/338342a0 · DOI
  33. Collinge, 1996, A new variant of prion disease, Lancet, 347, 916, 10.1016/S0140-6736(96)91407-5 · DOI
  34. Will, 1996, A new variant of Creutzfeldt-Jakob disease in the UK, Lancet, 347, 921, 10.1016/S0140-6736(96)91412-9 · DOI
  35. Gallassi, 1996, Fatal familial insomnia: behavioral and cognitive features, Neurology, 46, 935, 10.1212/WNL.46.4.935 · DOI
  36. Tinuper, 1989, The thalamus participates in the regulation of the sleep–waking cycle: a clinico-pathological study in fatal familial thalamic degeneration, Electroencephalogr Clin Neurophysiol, 73, 117, 10.1016/0013-4694(89)90190-9 · DOI
  37. Plazzi, 1997, Motor overactivity and loss of motor circadian rhythm in fatal familial insomnia: an actigraphic study, Sleep, 20, 739, 10.1093/sleep/20.9.739 · DOI
  38. Portaluppi, 1994, Diurnal blood pressure variation and hormonal correlates in fatal familial insomnia, Hypertension, 23, 569, 10.1161/01.HYP.23.5.569 · DOI
  39. Avoni, 1991, Circadian hormonal rhythms in two new cases of fatal familial insomnia, Acta Neurol, 13, 574
  40. Montagna, 1995, Fatal familial insomnia: sleep, neuroendocrine and vegetative alterations, Adv Neuroimmunol, 5, 13, 10.1016/0960-5428(94)00042-M · DOI
  41. Portaluppi, 1995, Dissociated 24-hour patterns of somatotropin and prolactin in fatal familial insomnia, Neuroendocrinology, 61, 731, 10.1159/000126901 · DOI
  42. Portaluppi, 1994, Progressive disruption of the circadian rhythm of melatonin in fatal familial insomnia, J Clin Endocrinol Metab, 78, 1075
  43. Cortelli, 1997, Cerebral metabolism in fatal familial insomnia: relation to duration, neuropathology, and distribution of protease-resistant prion protein, Neurology, 49, 126, 10.1212/WNL.49.1.126 · DOI
  44. Bar, 2002, Serial positron emission tomographic findings in an atypical presentation of fatal familial insomnia, Arch Neurol, 59, 1815, 10.1001/archneur.59.11.1815 · DOI
  45. Gambetti, 1995, Fatal familial insomnia and familial Creutzfeldt-Jakob disease: clinical, pathological and molecular features, Brain Pathol, 5, 43, 10.1111/j.1750-3639.1995.tb00576.x · DOI
  46. Macchi, 1997, Diffuse thalamic degeneration in fatal familial insomnia: a morphometric study, Brain Res, 771, 154, 10.1016/S0006-8993(97)00902-5 · DOI
  47. Masullo, 2001, Does PRNP gene control the clinical and pathological phenotype of human spongiform transmissible encephalopathies?, Clin Neuropathol, 20, 19
  48. Guentchev, 1999, Selective neuronal vulnerability in human prion diseases: fatal familial insomnia differs from other types of prion diseases, Am JPathol, 155, 1453, 10.1016/S0002-9440(10)65459-4 · DOI
  49. Tschampa, 2002, Clinical findings in sporadic Creutzfeldt-Jakob disease correlate with thalamic pathology, Brain, 125, 2558, 10.1093/brain/awf253 · DOI
  50. Bosque, 1992, A PrP gene codon 178 base substitution and a 24-bp interstitial deletion in familial Creutzfeldt-Jakob disease, Neurology, 42, 1864, 10.1212/WNL.42.10.1864 · DOI
  51. Vnencak-Jones, 1992, Identification of heterogeneous PrP gene deletions in controls by detection of allele-specific heteroduplexes (DASH), Am J Hum Genet, 50, 871
  52. Petersen, 1994, A novel mechanism of phenotypic heterogeneity demonstrated by the effect of a polymorphism on a pathogenic mutation in the PRNP (prion protein gene), Mol Neurobiol, 8, 99, 10.1007/BF02780659 · DOI
  53. Kovàcs, 2002, Mutations of the prion protein gene phenotypic spectrum, J Neurol, 249, 1567, 10.1007/s00415-002-0896-9 · DOI
  54. Collinge, 2001, Prion diseases of humans and animals: their causes and molecular basis, Annu Rev Neurosci, 24, 519, 10.1146/annurev.neuro.24.1.519 · DOI · Paper page
  55. Puoti, 2000, Polymorphism at codon 129 of PRNP affects the phenotypic expression of Creutzfeldt-Jakob disease linked to E200K mutation, Ann Neurol, 48, 269, 10.1002/1531-8249(200008)48:2<269::AID-ANA24>3.0.CO;2-V · DOI
  56. Hauw, 2000, Neuropathologic variants of sporadic Creutzfeldt-Jakob disease and codon 129 of PrP gene, Neurology, 54, 1641, 10.1212/WNL.54.8.1641 · DOI
  57. Zerr, 1998, Detection of 14-3-3 protein in the cerebrospinal fluid supports the diagnosis of Creutzfeldt-Jakob disease, Ann Neurol, 43, 32, 10.1002/ana.410430109 · DOI
  58. Scaravilli, 2000, Sporadic fatal insomnia: a case study, AnnNeurol, 48, 665
  59. Petersen, 1996, Effect of the D178N mutation and the codon 129 polymorphism on the metabolism of the prion protein, J Biol Chem, 271, 12661, 10.1074/jbc.271.21.12661 · DOI
  60. James, 1997, Solution structure of a 142-residue recombinant prion protein corresponding to the infectious segment of the scrapie isoform, Proc Natl Acad SciUSA, 94, 10086, 10.1073/pnas.94.19.10086 · DOI
  61. Riek, 1998, Prion protein NMR structure and familial spongiform encephalopathies, Proc Natl Acad Sci USA, 95, 11667, 10.1073/pnas.95.20.11667 · DOI
  62. Parchi, 1998, Molecular pathology of fatal familial insomnia, Brain Pathol, 8, 539, 10.1111/j.1750-3639.1998.tb00176.x · DOI
  63. Lugaresi, 1998, The pathophysiology of fatal familial insomnia, Brain Pathol, 8, 521, 10.1111/j.1750-3639.1998.tb00173.x · DOI
  64. Dorandeu, 1998, Neuronal apoptosis in fatal familial insomnia, Brain Pathol, 8, 531, 10.1111/j.1750-3639.1998.tb00175.x · DOI
  65. Velayos, 1998, Afferent projections to the mediodorsal and anterior thalamic nuclei in the cat: anatomical-clinical correlations, Brain Pathol, 8, 549, 10.1111/j.1750-3639.1998.tb00177.x · DOI
  66. Steriade, 1993, Thalamocortical oscillations in the sleeping and aroused brain, Science, 262, 679, 10.1126/science.8235588 · DOI · Paper page
  67. Hess, 1944, Das Schlafsyndrom als Folge diencephaler Reizung, Helv Physiol Pharmacol Acta, 2, 305
  68. Stotz-Potter, 1998, Removal of GABAergic inhibition in the mediodorsal nucleus of the rat thalamus leads to increases in heart rate and blood pressure, Neurosci Lett, 247, 127, 10.1016/S0304-3940(98)00291-2 · DOI
  69. Benarroch, 1998, Dysautonomia in fatal familial ionsomnia as an indicator of the potential role of the thalamus in autonomic control, Brain Pathol, 8, 527, 10.1111/j.1750-3639.1998.tb00174.x · DOI
  70. Oppenheimer, 1998, Distribution of cardiovascular related cells within the human thalamus, Clin Auton Res, 8, 173, 10.1007/BF02281122 · DOI
  71. Jouvet, 1972, The role of monoamines and acetylcholine-containing neurons in the regulation of the sleep-waking cycle, Ergeb Physiol, 64, 166
  72. Moruzzi, 1969, Sleep and instinctive behavior, Arch Ital Biol, 107, 175
  73. Parmeggiani, 1964, A study on the central representation of sleep behaviour, Prog Brain Res, 6, 180, 10.1016/S0079-6123(08)63725-5 · DOI
  74. Villablanca, 1972, Sleep-wakefulness, EEG and behavioral studies of chronic cats without neocortex and striatum: the “diencephalic” cat, Arch Ital Biol, 110, 348
  75. Villablanca, 1972, Sleep-wakefulness, EEG and behavioral studies of chronic cats without the thalamus: the “athalamic” cat, Arch Ital Biol, 110, 383
  76. Marini, 1988, Changes in sleep-waking cycle induced by lesions of medialis dorsalis thalamic nuclei in the cat, Neurosci Lett, 85, 223, 10.1016/0304-3940(88)90355-2 · DOI
  77. Bassetti, 1996, Hypersomnia following paramedian thalamic stroke: a report of 12 patients, Ann Neurol, 39, 471, 10.1002/ana.410390409 · DOI
  78. Guilleminault, 1993, Pseudo-hypersomnia and pre-sleep behaviour with bilateral paramedian thalamic lesions, Brain, 116, 1549, 10.1093/brain/116.6.1549 · DOI
  79. Montagna, 2002, Bilateral paramedian thalamic syndrome: abnormal circadian wake-sleep and autonomic functions, J Neurol Neurosurg Psychiatry, 73, 772, 10.1136/jnnp.73.6.772 · DOI
  80. Bricolo, 1967, Insomnia after bilateral stereotactic thalamotomy in man, J Neurol Neurosurg Psychiatry, 30, 154, 10.1136/jnnp.30.2.154 · DOI
  81. Lugaresi, 2001, Agrypnia excitata: clinical features and pathophysiological implications, Sleep Med Rev, 5, 313, 10.1053/smrv.2001.0166 · DOI
  82. Montagna, 2002, Agrypnia excitata: a generalized overactivity syndrome and a useful concept in the neurophysiopathology of sleep, Clin Neurophysiol, 113, 552, 10.1016/S1388-2457(02)00022-6 · DOI
  83. Autret, 1995, Agrypnia, Neurophysiol Clin, 25, 360, 10.1016/0987-7053(96)84909-4 · DOI
  84. Kopelman, 1995, The Korsakoff syndrome, Br J Psychiatry, 166, 154, 10.1192/bjp.166.2.154 · DOI
  85. Liguori, 2001, Morvan's syndrome: peripheral and central nervous system and cardiac involvement with antibodies to voltage-gated potassium channels, Brain, 124, 2417, 10.1093/brain/124.12.2417 · DOI
  86. Barber, 2000, Morvan's syndrome associated with voltage-gated K+channel antibodies, Neurology, 54, 771, 10.1212/WNL.54.3.771 · DOI
  87. Gross, 1973, Experimental study of sleep in chronic alcoholics before, during, and after four days of heavy drinking with a nondrinking comparison, Ann N Y Acad Sci, 215, 254, 10.1111/j.1749-6632.1973.tb28281.x · DOI
  88. Ishibashi, 1987, Cerebral atrophy and slow wave sleep of abstinent chronic alcoholics, Drug Alcohol Depend, 19, 325, 10.1016/0376-8716(87)90019-6 · DOI
  89. Kotorii, 1980, The sleep pattern of chronic alcoholics during the alcohol withdrawal period, Folia Psych Neurol Jpn, 34, 89
  90. Plazzi, 2002, Polysomnographic study of sleeplessness and oneiricisms in the alcohol withdrawal syndrome, Sleep Med, 3, 279, 10.1016/S1389-9457(02)00014-X · DOI
  91. Wanschitz, 2000, Alteration of the serotonergic nervous system in fatal familial insomnia, Ann Neurol, 48, 788, 10.1002/1531-8249(200011)48:5<788::AID-ANA13>3.0.CO;2-5 · DOI
  92. Cortelli, 2001, Alteration of the serotoninergic system in fatal familial insomnia, Ann Neurol, 50, 421, 10.1002/ana.1145 · DOI
  93. Kloppel, 2002, Beta-CIT SPECT demonstrates reduced availability of serotonin transporters in patients with fatal familial insomnia, J Neural Transm, 109, 1105, 10.1007/s007020200093 · DOI
  94. Cross, 1985, Neurotransmitter metabolites, enzymes and receptors in experimental scrapie, J Neurol Sci, 70, 231, 10.1016/0022-510X(85)90090-5 · DOI
  95. Bassant, 1986, Changes in the serotonergic, noradrenergic and dopaminergic levels in the brain of scrapie-infected rats, Brain Res, 367, 360, 10.1016/0006-8993(86)91619-7 · DOI
  96. Goudsmit, 1981, Hypersensitivity to central serotonin receptor activation in scrapie-infected hamsters and the effect of serotonergic drugs on scrapie symptoms, Brain Res, 220, 372, 10.1016/0006-8993(81)91228-2 · DOI
  97. Rohwer, 1981, Serotonin concentrations in brain and blood of scrapie-infected and normal hamsters and mice, Brain Res, 220, 367, 10.1016/0006-8993(81)91227-0 · DOI
  98. Pocchiari, 1985, Serotoninergic system in scrapie-infected hamsters, J Neurochem, 44, 862, 10.1111/j.1471-4159.1985.tb12895.x · DOI
  99. Wiklund, 1981, Morphological and functional studies on the serotoninergic innervation of the inferior olive, J Physiol (Paris), 77, 183
  100. Welsh, 1998, Removal of the inferior olive abolishes myoclonic seizures associated with a loss of olivary serotonin, Neuroscience, 82, 879, 10.1016/S0306-4522(97)00297-2 · DOI
  101. Welsh, 2002, The serotonin hypothesis of myoclonus from the perspective of neuronal rhythmicity, Adv Neurol, 89, 307
  102. Tobler, 1997, Sleep and sleep regulation in normal and prion protein-deficient mice, J Neurosci, 17, 1869, 10.1523/JNEUROSCI.17-05-01869.1997 · DOI
  103. Tobler, 1996, Altered circadian activity rhythms and sleep in mice devoid of prion protein, Nature, 380, 639, 10.1038/380639a0 · DOI
  104. Fiorino, 1996, Sleep, genes and death: fatal familial insomnia, Brain Res Brain Res Rev, 22, 258, 10.1016/S0165-0173(96)00010-0 · DOI
  105. Terzano, 1995, Precocious loss of physiological sleep in a case of Creutzfeldt Jakob disease: a serial polygraphic study, Sleep, 18, 849
  106. Vitrey, 1971, Two sleep records obtained during the course of Jakob Creutzfeldt disease, Electroencephalogr Clin Neurophysiol, 30, 253
  107. Gourmelon, 1987, Sleep abnormalities with REM disorder in experimental Creutzfeldt-Jakob disease in cats: a new pathological feature, Brain Res, 411, 391, 10.1016/0006-8993(87)91093-6 · DOI
  108. Bert, 1978, Experimental kuru in the rhesus monkey: a study of EEG modifications in the waking state and during sleep, Electroencephalogr Clin Neurophysiol, 45, 611, 10.1016/0013-4694(78)90161-X · DOI
  109. Bessen, 1992, Identification of two biologically distinct strains of transmissible mink encephalopathy in hamsters, J Gen Virol, 73, 329, 10.1099/0022-1317-73-2-329 · DOI
  110. Bessen, 1994, Distinct PrP properties suggest the molecular basis of strain variation in transmissible mink encephalopathy, J Virol, 68, 7859, 10.1128/jvi.68.12.7859-7868.1994 · DOI
  111. Dell'Omo, 2002, Early behavioural changes in mice infected with BSE and scrapie: automated home cage monitoring reveals prion strain differences, Eur J Neurosci, 16, 735, 10.1046/j.1460-9568.2002.02128.x · DOI
  112. Sghirlanzoni, 2000, The insomnia plague: a Gabriel Garcia Marquez story, Neurol Sci, 21, 251, 10.1007/s100720070085 · DOI
  113. Taniwaki, 2000, Familial Creutzfeldt-Jakob disease with D178N-129M mutation of PRNP presenting as cerebellar ataxia without insomnia, J Neurol Neurosurg Psychiatry, 68, 388, 10.1136/jnnp.68.3.388 · DOI
  114. McLean, 1997, Diverse clinicopathologic phenotypes in an FFI Australian kindred, Neurology, 49, 552, 10.1212/WNL.49.2.552 · DOI
  115. Zerr, 1998, Phenotypic variability in fatal familial insomnia (D178N-129M) genotype, Neurology, 51, 1398, 10.1212/WNL.51.5.1398 · DOI
  116. Rossi, 1998, Fatal familial insomnia: genetic, neuropathologic, and biochemical study of a patient from a new Italian kindred, Neurology, 50, 688, 10.1212/WNL.50.3.688 · DOI
  117. Johnson, 1998, Fatal familial insomnia: clinical and pathologic heterogeneity in genetic half brothers, Neurology, 51, 1715, 10.1212/WNL.51.6.1715 · DOI
  118. Rechtschaffen, 2002, Sleep deprivation in the rat: X: integration and discussion of the findings. 1989, Sleep, 25, 68, 10.1093/sleep/25.1.68 · DOI
  119. Wu, 1991, The effect of sleep deprivation on cerebral glucose metabolic rate in normal humans assessed with positron emission tomography, Sleep, 14, 155

Cited by

Sorted by citations

Metadata

Authors
Montagna, P., Gambetti, P., Cortelli, P., & Lugaresi, E.
Affiliations
  • University of Bologna (IT)
  • Case Western Reserve University (US)
  • University of Modena and Reggio Emilia (IT)
Corresponding author
Lugaresi, Elio
Venue
The Lancet Neurology
Publisher
Elsevier BV
Published
2003-03
Volume
2
Issue
3
Pages
167-176
ISSN
1474-4422 (ISSN-L)
OpenAlex
W2069064263
Cited by
354
References
2
Citations by year
2026: 6 · 2025: 9 · 2024: 11 · 2023: 31 · 2022: 11 · 2021: 17 · 2020: 11 · 2019: 19 · 2018: 15 · 2017: 22 · 2016: 26 · 2015: 13 · 2014: 16 · 2013: 21 · 2012: 16
FWCI
1.00
Type
journal article
Language
en
Open access
closed
Locations
  • The Lancet Neurology (publishedVersion)
  • PubMed (publishedVersion)
Funders
European Commission (BMH4-CT96-0856)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Prion Diseases and Protein Misfolding
  • Health Sciences › Medicine › Internal Medicine › Amyloidosis: Diagnosis, Treatment, Outcomes
  • Life Sciences › Neuroscience › Cognitive Neuroscience › Sleep and Wakefulness Research
Keywords
prion disease, prion protein, thalamic hypometabolism, inferior olive, PRNP codon 129 polymorphism, prion strains, sleep spindles, sleep regulation, clinicopathological correlation
MeSH terms
Prion Proteins, Amyloid, Brain, Diagnosis, Differential, Diagnostic Imaging, DNA Mutational Analysis, Electroencephalography, Humans, Nerve Degeneration, Prions, Protein Precursors, Thalamus, Insomnia, Fatal Familial

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review